The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness

Critical Care

Volumn 5, Issue SUPPL. 2, 2001, Pages

  Esmon, Charles T ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Activated Protein C; Coagulation; Endothelial cell Protein C receptor (EPCR); Inflammation, thrombomodulin

Indexed keywords

PROTEIN C; THROMBOMODULIN;

ANIMAL; BLOOD CLOTTING; CRITICAL ILLNESS; HOMEOSTASIS; HUMAN; INFLAMMATION; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; SEPSIS;

ANIMALS; BLOOD COAGULATION; CRITICAL ILLNESS; HOMEOSTASIS; HUMANS; INFLAMMATION; MICROCIRCULATION; PROTEIN C; SEPSIS; THROMBOMODULIN;

EID: 0035222641     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1333     Document Type: Article

References (23)

1. Esmon C: Cell mediated events that control blood coagulation and vascular injury. Ann Rev Cell Devel Biol 1993, 9:1-26.
2. Waugh JM, Li-Hawkins J, Yuksel E, Kuo MD, Cifra PN, Hilfiker PR, Geske R, Chawla M, Thomas J, Shenaq SM, Dake MD, Woo SLC: Thrombomodulin overexpression to limit neointima formation. Circulation 2000, 102:332-337.
3. Esmon CT: Natural anticoagulants and their pathways. In: Antithrombotics (Handbook of Experiemental Pharmacology, vol 132. Edited by Uprichard ACG, Gallagher KP. Heidelberg: Springer-Verlag; 1999:447-476.
4. Fukudome K, Esmon CT: Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994, 269:26486-26491.
5. Esmon CT: The endothelial cell protein C receptor. Thromb Haemost 2000, 83:639-643.
6. Busch C, Cancilla P, DeBault L, Goldsmith J, Owen W: Use of endothelium cultured on microcarriers as a model for the microcirculation. Lab Invest 1982, 47:498-504..
7. Fuentes-Prior P, Iwanaga Y, Huber R, Pagila R, Rumennik G, Seto M, Morser J, Light DR, Bode W: Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 2000, 404:518-525.
8. Smith OP, White B: Infectious purpura fulminans: diagnosis and treatment Br J Haematol 1999, 104:202-207.
9. Esmon CT: Inflammation and thrombosis: mutual regulation by protein C. The Immunologist 1998, 6:84-89.
10. Esmon CT, Fukudome K, Mather T, Bode W, Esmon NL, Regan LM, Stearns-Kurosawa DJ, Kurosawa S: Inflammation: the protein C pathway. Fibrinolysis Proteolysis 1997, 11:143-148.
11. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987, 79:918-925.
12. Taylor F, Chang A, Ferrell G, Mather T, Catlett R, Blick K, Esmon CT: C4b-binding protein exacerbates the host response to Escherichia coli. Blood 1991, 78:357-363.
13. Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ: Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 1985, 82:1121-1125.
14. Bajzar L, Morser J, Nesheim M: TAFI or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996, 271:16603-16608.
15. Bajzar L, Manuel R, Nesheim ME: Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995, 270:14477-14484.
16. Taoka Y, Okajima K, Uchiba M, Murakami K, Harada N, Johno M, Naruo M: Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. J Neurosci 1998, 18:1393-1398.
17. Mizutani A, Okajima K, Uchiba M, Noguchi T: Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000, 95:3781-3787.
18. Esmon CT: Activated Protein C. London: ReMedica Publishing; 2001:in press.
19. Kurosawa S, Esmon CT, Stearns-Kurosawa DJ: The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. J Immunol 2000, 165:4697-4703.
20. White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, Lawler M, O'Neill L, Kelleher D, Schwarz HP, Smith OP: Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor κB (NF-κB) and tumour necrosis factor α (TNF-α) production in the THP-1 monocytic cell line. Br J Haematol 2000, 110:130-134.
21. Hancock WW, Grey ST, Hau L, Akalin E, Orthner C, Sayegh MH, Salem HH: Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation 1995, 60:1525-1532.
22. Shu F, Kobayashi H, Fukudome K, Tsuneyoshi N, Kimoto M, Terao T: Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Lett 2000, 477:208-212.
23. Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang ACK, Laszik Z, Kosanke S, Peer G, Esmon CT: The endothelial cell protein C receptor aids in host defence against Escherichia coli sepsis. Blood 2000, 95:1680-1686.